PMID: 20623887Jul 14, 2010Paper

Chronic hepatitis B: antiviral treatment guidelines

La Revue du praticien
Christophe Hézode, Jean-Michel Pawlotsky

Abstract

The main goals of chronic hepatitis B therapy are, sustained reduction of HBV DNA below the limit of detection of real-time PCR (10-15 IU/mL), biochemical remission (ALT normalization) and histological improvement, in order to prevent disease progression associated with cirrhosis and hepatocellular carcinoma. In HBeAg positive patients, the objective is to achieve durable HBe seroconversion and/or in all patients lost of HBsAg, with or without anti-HBs seroconversion. Antiviral treatment is recommended in patients with HBV DNA levels above 2000 IU/ml and/or elevated ALT values and histological findings in liver biopsy over A1F1. The treatment may be a first line of pegylated interferon for 48 weeks in patients who have factors related to virological response. The other strategy is based on long-term administration of a nucleos (t) ide analogue with a potent antiviral activity and good patterns of resistance and safety (entecavir or tenofovir).

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Related Papers

Acta Medica Croatica : C̆asopis Hravatske Akademije Medicinskih Znanosti
Miro MorovićRajko Ostojić
The International Journal of Artificial Organs
Fabrizio FabriziPietro Lampertico
Best Practice & Research. Clinical Gastroenterology
Rong-Nan Chien, Yun-Fan Liaw
Expert Review of Anti-infective Therapy
Vito Di Marco, Antonio Craxì
© 2021 Meta ULC. All rights reserved